Alentis Therapeutics Reports Positive Topline Results From Phase 1 Multiple-ascending Dose Cohorts Study
The trial confirms ALE.F02’s good safety profile, exposure and target biological activity BASEL, Switzerland--(BUSINESS WIRE)--Alentis…
The trial confirms ALE.F02’s good safety profile, exposure and target biological activity BASEL, Switzerland--(BUSINESS WIRE)--Alentis…
The new store invites the local community to discover the best of Apple SHENZHEN, China--(BUSINESS…
onsemi EliteSiC devices will help extend the range of ZEEKR’s smart electric vehicles (EVs) SCOTTSDALE,…
The luxury lifestyle hotel offers contemporary guestrooms, creative spaces, unscripted service and vibrant programming to…
Companies to focus on further integrating their robots and controllers and developing new technologies for…
James Hardie Reaches Commercial Agreement with Plaintiff Ending Waitakere Litigation SYDNEY & CHICAGO--(BUSINESS WIRE)--James Hardie…
SEATTLE--(BUSINESS WIRE)--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it…
SYDNEY--(BUSINESS WIRE)--Ryan, a leading global tax services and software provider, has announced that Jason Dunnachie…
During the President of the Republic of Korea’s visit to the United States, NuScale and…
MAINTAINED A SOLID BALANCE SHEET WITH $21.4 MILLION IN CASH SOLD 10,055 GOLD EQUIVALENT OUNCES…